$UPWK
UPWORK, INC Stock $upwk

$upwk Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000162747521000032 Filed on July 29, 2021

Income Statement

Concept	2021 Q2	2020 Q2	2020 Q1
Revenue	$124.2M	$87.53M	$83.20M
YoY Change	41.87%	18.63%	21.5%
Cost Of Revenue	$33.08M	$25.41M	$23.49M
YoY Change	30.21%	17.7%	11.17%
Gross Profit	$91.10M	$62.12M	$59.71M
YoY Change	46.64%	19.02%	26.1%
Gross Profit Margin	73.36%	70.97%	71.77%
Selling, General & Admin	$78.17M	$51.54M	$48.50M
YoY Change	51.67%	33.73%	34.06%
% of Gross Profit	85.81%	82.97%	81.23%
Research & Development	$28.12M	$20.55M	$19.35M
YoY Change	36.88%	30.91%	22.46%
% of Gross Profit	30.87%	33.07%	32.4%
Depreciation & Amortization	$1.000M	$800.0K	$700.0K
YoY Change	25.0%	33.33%	-12.5%
% of Gross Profit	1.1%	1.29%	1.17%
Operating Expenses	$107.5M	$73.11M	$68.76M
YoY Change	47.04%	32.7%	30.69%
Operating Profit	-$16.40M	-$10.98M	-$9.051M
YoY Change	49.26%	278.89%	71.91%
Interest Expense	$110.0K	$258.0K	$230.0K
YoY Change	-57.36%	-27.73%	-38.34%
% of Operating Profit
Other Income/Expense, Net	-$17.00K	$248.0K	-$731.0K
YoY Change	-106.85%	-70.19%	-252.61%
Pretax Income	-$16.52M	-$10.99M	-$10.01M
YoY Change	50.28%	353.55%	94.07%
Income Tax	$16.00K	$30.00K	$9.000K
% Of Pretax Income
Net Earnings	-$16.54M	-$11.02M	-$10.02M
YoY Change	50.02%	349.78%	94.21%
Net Earnings / Revenue	-13.32%	-12.59%	-12.05%
Basic Earnings Per Share	-$0.13	-$0.09
Diluted Earnings Per Share	-$0.13	-$0.09	-$87.64K
COMMON SHARES
Basic Shares Outstanding	126.7M shares	116.5M shares	113.9M shares
Diluted Shares Outstanding	126.7M shares	116.5M shares

Balance Sheet

Concept	2021 Q2	2020 Q2	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$172.4M	$146.4M	$145.3M
YoY Change	17.79%	13.05%	19.88%
Cash & Equivalents	$131.4M	$76.76M	$65.64M
Short-Term Investments	$40.99M	$69.60M	$79.70M
Other Short-Term Assets	$177.6M	$138.6M	$132.0M
YoY Change	28.14%	10.97%	4.1%
Inventory
Prepaid Expenses
Receivables	$62.23M	$33.23M	$35.26M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$412.3M	$318.2M	$312.5M
YoY Change	29.58%	4.03%	5.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.68M	$27.28M	$24.99M
YoY Change	-13.2%	42.05%	98.26%
Goodwill	$118.2M	$118.2M	$118.2M
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.406M	$1.546M	$1.040M
YoY Change	-9.06%	58.4%	-25.13%
Total Long-Term Assets	$157.0M	$170.7M	$169.5M
YoY Change	-8.03%	19.31%	23.25%
TOTAL ASSETS
Total Short-Term Assets	$412.3M	$318.2M	$312.5M
Total Long-Term Assets	$157.0M	$170.7M	$169.5M
Total Assets	$569.3M	$488.8M	$482.1M
YoY Change	16.45%	8.9%	11.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.625M	$5.180M	$1.719M
YoY Change	66.51%	240.57%	11.48%
Accrued Expenses	$33.21M	$25.40M	$23.40M
YoY Change	30.75%	32.98%	50.0%
Deferred Revenue	$19.16M	$14.98M	$14.39M
YoY Change	27.9%	1226.02%	32.79%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.344M	$7.594M	$22.59M
YoY Change	-16.46%	-76.69%	-30.64%
Total Short-Term Liabilities	$232.4M	$182.7M	$185.6M
YoY Change	27.23%	5.8%	8.76%
LONG-TERM LIABILITIES
Long-Term Debt	$633.0K	$6.929M	$8.814M
YoY Change	-90.86%	-52.11%	-46.1%
Other Long-Term Liabilities	$8.916M	$6.996M	$6.384M
YoY Change	27.44%	68.66%	129.64%
Total Long-Term Liabilities	$9.549M	$13.93M	$15.20M
YoY Change	-31.43%	-25.2%	-20.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$232.4M	$182.7M	$185.6M
Total Long-Term Liabilities	$9.549M	$13.93M	$15.20M
Total Liabilities	$260.7M	$218.7M	$223.3M
YoY Change	19.22%	14.34%	17.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$219.2M	-$193.0M	-$182.0M
YoY Change	13.57%	28.45%	22.77%
Common Stock	$527.7M	$463.1M	$440.7M
YoY Change	13.94%	13.55%	12.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$308.5M	$270.1M	$258.7M
YoY Change
Total Liabilities & Shareholders Equity	$569.3M	$488.8M	$482.1M
YoY Change	16.45%	8.9%	11.13%

Cashflow Statement

Concept	2021 Q2	2020 Q2	2020 Q1
OPERATING ACTIVITIES
Net Income	-$16.54M	-$11.02M	-$10.02M
YoY Change	50.02%	349.78%	94.21%
Depreciation, Depletion And Amortization	$1.000M	$800.0K	$700.0K
YoY Change	25.0%	33.33%	-12.5%
Cash From Operating Activities	$540.0K	$8.360M	-$1.702M
YoY Change	-93.54%	432.48%	-94.21%
INVESTING ACTIVITIES
Capital Expenditures	-$1.545M	-$5.900M	$1.288M
YoY Change	-73.81%	22.66%	-64.26%
Acquisitions
YoY Change
Other Investing Activities	$24.51M	$10.04M	$6.210M
YoY Change	144.15%	1.01%	-108.66%
Cash From Investing Activities	$22.96M	$4.150M	$2.924M
YoY Change	453.2%	-19.42%	-103.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	7.609M	4.610M	$31.11M
YoY Change	65.05%	-51.37%	-34.74%
NET CHANGE
Cash From Operating Activities	540.0K	8.360M	-$1.702M
Cash From Investing Activities	22.96M	4.150M	$2.924M
Cash From Financing Activities	7.609M	4.610M	$31.11M
Net Change In Cash	31.11M	17.12M	$32.33M
YoY Change	81.7%	5.68%	-155.49%
FREE CASH FLOW
Cash From Operating Activities	$540.0K	$8.360M	-$1.702M
Capital Expenditures	-$1.545M	-$5.900M	$1.288M
Free Cash Flow	$2.085M	$14.26M	-$2.990M
YoY Change	-85.38%	123.51%	-90.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001627475
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38678
	dei	Entity Registrant Name EntityRegistrantName	UPWORK INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4337682
	dei	Entity Address Address Line1 EntityAddressAddressLine1	475 Brannan Street, Suite 430
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94107
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	316-7500
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	UPWK
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	127616789	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	131448000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94081000	USD
CY2021Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	40990000	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	75570000	USD
CY2021Q2	us-gaap	Escrow Deposit EscrowDeposit	165082000	USD
CY2020Q4	us-gaap	Escrow Deposit EscrowDeposit	135042000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1886000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1661000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	62232000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47018000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12526000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9090000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	412278000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	360801000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23683000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28139000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	118219000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	118219000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	667000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13674000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19729000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1406000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1672000	USD
CY2021Q2	us-gaap	Assets Assets	569260000	USD
CY2020Q4	us-gaap	Assets Assets	529227000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	8625000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6455000	USD
CY2021Q2	upwk	Escrow Funds Payable EscrowFundsPayable	165082000	USD
CY2020Q4	upwk	Escrow Funds Payable EscrowFundsPayable	135042000	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	6344000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7581000	USD
CY2021Q2	upwk	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	33211000	USD
CY2020Q4	upwk	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	32868000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	19164000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	16801000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	232426000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	198747000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	633000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3142000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18757000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20506000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8916000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7522000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	260732000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	229917000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	299310000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	569260000	USD
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127616789	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127616789	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	124795222	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	124795222	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	13000	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	527712000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	494122000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-219197000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194824000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	308528000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	529227000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	124181000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	87531000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	237800000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	170727000	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33083000	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	25408000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	63524000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	48893000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	91098000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	62123000	USD
	us-gaap	Gross Profit GrossProfit	174276000	USD
	us-gaap	Gross Profit GrossProfit	121834000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28124000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20547000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	54737000	USD
CY2020Q2	upwk	Provision For Transaction Losses ProvisionForTransactionLosses	1018000	USD
	upwk	Provision For Transaction Losses ProvisionForTransactionLosses	2324000	USD
	upwk	Provision For Transaction Losses ProvisionForTransactionLosses	1930000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-16395000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39895000	USD
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	45817000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34440000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	85421000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	65118000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32355000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17102000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	55886000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34926000	USD
CY2021Q2	upwk	Provision For Transaction Losses ProvisionForTransactionLosses	1197000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	107493000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	73107000	USD
	us-gaap	Operating Expenses OperatingExpenses	198368000	USD
	us-gaap	Operating Expenses OperatingExpenses	141869000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-10984000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24092000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20035000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	110000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	258000	USD
	us-gaap	Interest Expense InterestExpense	309000	USD
	us-gaap	Interest Expense InterestExpense	488000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	248000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	61000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-483000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16522000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10994000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24340000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21006000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-11024000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24373000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-16538000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-21045000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126742000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126742000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	116524000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	116524000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126011000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126011000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	115321000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	115321000	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	305501000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3130000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13562000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	185000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2688000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-16538000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	308528000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	258736000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12845000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6866000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	59000	USD
CY2020Q2	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	264244	shares
CY2020Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2661000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-11024000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	270143000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	299310000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5727000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24826000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	350000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2688000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24373000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	308528000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	259424000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16010000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12193000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	900000	USD
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	264244	shares
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2661000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-21045000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	270143000	USD
	us-gaap	Profit Loss ProfitLoss	-24373000	USD
	us-gaap	Profit Loss ProfitLoss	-21045000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1907000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1606000	USD
	upwk	Depreciation And Amortization Excluding Amortization Of Financing Costs DepreciationAndAmortizationExcludingAmortizationOfFinancingCosts	5748000	USD
	upwk	Depreciation And Amortization Excluding Amortization Of Financing Costs DepreciationAndAmortizationExcludingAmortizationOfFinancingCosts	4786000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	39000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	26000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-22000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	257000	USD
	upwk	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	1774000	USD
	upwk	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	1945000	USD
	upwk	Increase Decrease In Common Stock Warrant IncreaseDecreaseInCommonStockWarrant	375000	USD
	upwk	Increase Decrease In Common Stock Warrant IncreaseDecreaseInCommonStockWarrant	376000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	24760000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	12671000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	7389000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1585000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2420000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6662000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	29967000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16835000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4773000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2871000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	968000	USD
	upwk	Increase Decrease Operating Lease Liability IncreaseDecreaseOperatingLeaseLiability	-861000	USD
	upwk	Increase Decrease Operating Lease Liability IncreaseDecreaseOperatingLeaseLiability	-925000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2168000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4403000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-273000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	7232000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3451000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	47748000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	64500000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	64000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	334000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5627000	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3581000	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3559000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	30618000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7066000	USD
	upwk	Changes In Escrow Funds Payable ChangesInEscrowFundsPayable	30040000	USD
	upwk	Changes In Escrow Funds Payable ChangesInEscrowFundsPayable	20832000	USD
	upwk	Proceeds From Exercises Of Stock Options And Common Stock Warrant ProceedsFromExercisesOfStockOptionsAndCommonStockWarrant	5727000	USD
	upwk	Proceeds From Exercises Of Stock Options And Common Stock Warrant ProceedsFromExercisesOfStockOptionsAndCommonStockWarrant	16010000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	18000000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	3786000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	21786000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2688000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	2661000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	34669000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35717000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	67707000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49445000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232463000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	159603000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	300170000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	209048000	USD
	us-gaap	Interest Paid Net InterestPaidNet	283000	USD
	us-gaap	Interest Paid Net InterestPaidNet	499000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	39000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	478000	USD
CY2021Q2	us-gaap	Capitalized Costs Asset Retirement Costs CapitalizedCostsAssetRetirementCosts	36000	USD
CY2020Q2	us-gaap	Capitalized Costs Asset Retirement Costs CapitalizedCostsAssetRetirementCosts	170000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the periods presented. Such estimates include, but are not limited to: the useful lives of assets; assessment of the recoverability of long-lived assets; goodwill impairment; standalone selling price of material rights and the period of time over which to defer and recognize the consideration allocated to the material rights; allowance for doubtful accounts; liabilities relating to transaction losses; stock-based compensation; and accounting for income taxes. Management bases its estimates on historical experience and on various other assumptions that management believes to be reasonable under the circumstances. The Company evaluates its estimates, assumptions, and judgments on an ongoing basis using historical experience and other factors and revises them when facts and circumstances dictate.</span></div>
CY2021Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	7400000	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	24400000	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	19200000	USD
CY2021Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	62232000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47018000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	19164000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	16801000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	5265000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	4177000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	6100000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	9600000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4900000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8000000.0	USD
CY2021Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	160796000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	147292000	USD
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	7000000.0	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10800000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	131448000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94081000	USD
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	3640000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	3340000	USD
CY2021Q2	upwk	Funds Held In Escrow Including Funds In Transit FundsHeldInEscrowIncludingFundsInTransit	165082000	USD
CY2020Q4	upwk	Funds Held In Escrow Including Funds In Transit FundsHeldInEscrowIncludingFundsInTransit	135042000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	300170000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232463000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	44121000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	43513000	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20438000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15374000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23683000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28139000	USD
CY2021Q2	us-gaap	Depreciation Depreciation	1000000.0	USD
CY2020Q2	us-gaap	Depreciation Depreciation	800000	USD
	us-gaap	Depreciation Depreciation	2000000.0	USD
	us-gaap	Depreciation Depreciation	1500000	USD
CY2021Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1300000	USD
CY2020Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1700000	USD
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	3400000	USD
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	3300000	USD
CY2021Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1600000	USD
CY2020Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1100000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	3100000	USD
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2000000.0	USD
CY2021Q2	upwk	Lessor Operating Lease Lease Not Yet Commenced Undiscounted Amount Per Month LessorOperatingLeaseLeaseNotYetCommencedUndiscountedAmountPerMonth	100000	USD
CY2021Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	7400000	USD
CY2021Q2	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	4300000	USD
CY2021Q2	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	2900000	USD
CY2021Q2	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	200000	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	USD
CY2021Q2	upwk	Accrued Compensation And Related Benefits Current AccruedCompensationAndRelatedBenefitsCurrent	12100000	USD
CY2020Q4	upwk	Accrued Compensation And Related Benefits Current AccruedCompensationAndRelatedBenefitsCurrent	14007000	USD
CY2021Q2	upwk	Accrued Freelancer Costs Current AccruedFreelancerCostsCurrent	1141000	USD
CY2020Q4	upwk	Accrued Freelancer Costs Current AccruedFreelancerCostsCurrent	1235000	USD
CY2021Q2	upwk	Accrued Indirect Taxes Current AccruedIndirectTaxesCurrent	3037000	USD
CY2020Q4	upwk	Accrued Indirect Taxes Current AccruedIndirectTaxesCurrent	3818000	USD
CY2021Q2	upwk	Accrued Vendor Expenses Current AccruedVendorExpensesCurrent	9921000	USD
CY2020Q4	upwk	Accrued Vendor Expenses Current AccruedVendorExpensesCurrent	8662000	USD
CY2021Q2	upwk	Accrued Payment Processing Fees Current AccruedPaymentProcessingFeesCurrent	2079000	USD
CY2020Q4	upwk	Accrued Payment Processing Fees Current AccruedPaymentProcessingFeesCurrent	1219000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4613000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3725000	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	320000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	202000	USD
CY2021Q2	upwk	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	33211000	USD
CY2020Q4	upwk	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	32868000	USD
CY2020Q4	upwk	Letters Of Credit Held LettersOfCreditHeld	3	letter
CY2021Q2	upwk	Letters Of Credit Held LettersOfCreditHeld	3	letter
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	6964000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10750000	USD
CY2021Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-13000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	27000	USD
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	6977000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	10723000	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	6344000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7581000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	633000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3142000	USD
CY2021Q2	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0510
CY2020Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0564
CY2021Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	49000000.0	USD
	upwk	Adjusted Liquidity Ratio AdjustedLiquidityRatio	1.75
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-16538000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-11024000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24373000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-21045000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126742452	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126742452	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	116523570	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	116523570	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126010689	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126010689	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	115321264	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	115321264	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10390746	shares
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17484848	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	124181000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	87531000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	237800000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	170727000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	124181000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	87531000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	237800000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	170727000	USD

Files In Submission

Name	View Source	Status
0001627475-21-000032-index-headers.html	Edgar Link	pending
0001627475-21-000032-index.html	Edgar Link	pending
0001627475-21-000032.txt	Edgar Link	pending
0001627475-21-000032-xbrl.zip	Edgar Link	pending
exhibit3112q21.htm	Edgar Link	pending
exhibit3122q21.htm	Edgar Link	pending
exhibit3212q21.htm	Edgar Link	pending
exhibit3222q21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
upwk-20210630.htm	Edgar Link	pending
upwk-20210630.xsd	Edgar Link	pending
upwk-20210630_cal.xml	Edgar Link	unprocessable
upwk-20210630_def.xml	Edgar Link	unprocessable
upwk-20210630_htm.xml	Edgar Link	completed
upwk-20210630_lab.xml	Edgar Link	unprocessable
upwk-20210630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UPWK
UPWORK, INC Stock $upwk

2021 Q2 Form 10-Q Financial Statement

#000162747521000032 Filed on July 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UPWK UPWORK, INC Stock $upwk

2021 Q2 Form 10-Q Financial Statement

#000162747521000032 Filed on July 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UPWK
UPWORK, INC Stock $upwk